{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:01:57Z","timestamp":1788904917250,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mayocp.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:28:26Z","timestamp":1782257306000},"page":"1367-1379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Physiologic Basis of Acute Glomerular Filtration Rate Decline With Renoprotective Therapies"],"prefix":"10.1016","volume":"101","author":[{"given":"Fatima","family":"Ayub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Juncos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4-5","key":"10.1016\/j.mayocp.2026.06.015_bib1","first-page":"215","article-title":"Pathophysiology of renal hemodynamics","volume":"27","author":"Maher","year":"1981","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.mayocp.2026.06.015_bib2","doi-asserted-by":"crossref","first-page":"F624","DOI":"10.1152\/ajprenal.00239.2020","article-title":"Impaired renal hemodynamics and glomerular hyperfiltration contribute to hypertension-induced renal injury","volume":"319","author":"Fan","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.mayocp.2026.06.015_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00467-016-3358-9","article-title":"Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis","volume":"32","author":"Kriz","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.mayocp.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.mayocp.2026.01.010","article-title":"Acute estimated glomerular filtration rate decline after initiation of therapies that slow kidney disease progression: clinical practice implications","volume":"101","author":"Cherney","year":"2026","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2026.06.015_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"Haraldsson","year":"2008","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2026.06.015_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-008-0961-8","article-title":"What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?","volume":"51","author":"Satchell","year":"2008","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.mayocp.2026.06.015_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.yexcr.2012.02.031","article-title":"The glomerular basement membrane","volume":"318","author":"Miner","year":"2012","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.mayocp.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"Pavenstadt","year":"2003","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1152\/ajplegacy.1972.223.5.1178","article-title":"A model of glomerular ultrafiltration in the rat","volume":"223","author":"Deen","year":"1972","journal-title":"Am J Physiol"},{"issue":"pt 2","key":"10.1016\/j.mayocp.2026.06.015_bib10","first-page":"F879","article-title":"Autoregulation of afferent arteriolar blood flow in juxtamedullary nephrons","volume":"267","author":"Takenaka","year":"1994","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.06.015_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.2008.145","article-title":"Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice","volume":"74","author":"Schnermann","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.mayocp.2026.06.015_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.ph.49.030187.001343","article-title":"The tubuloglomerular feedback mechanism: functional and biochemical aspects","volume":"49","author":"Briggs","year":"1987","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.1016\/j.mayocp.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.1996.76.2.425","article-title":"Paracrine regulation of the renal microcirculation","volume":"76","author":"Navar","year":"1996","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2026.06.015_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.mayocp.2026.06.015_bib15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/HYPERTENSIONAHA.110.153692","article-title":"Angiotensin II enhances connecting tubule glomerular feedback","volume":"56","author":"Ren","year":"2010","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mayocp.2026.06.015_bib16","doi-asserted-by":"crossref","first-page":"F427","DOI":"10.1152\/ajprenal.00072.2014","article-title":"Aldosterone sensitizes connecting tubule glomerular feedback via the aldosterone receptor GPR30","volume":"307","author":"Ren","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.mayocp.2026.06.015_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ki.1983.72","article-title":"Hemodynamically mediated glomerular injury and the progressive nature of kidney disease","volume":"23","author":"Brenner","year":"1983","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.mayocp.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.mayocp.2026.06.015_bib19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.1996.03530440061038","article-title":"The role of the kidney in hypertension","volume":"275","author":"Cowley","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2026.06.015_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2026.06.015_bib21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ki.2014.143","article-title":"Endothelin and endothelin antagonists in chronic kidney disease","volume":"86","author":"Kohan","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mayocp.2026.06.015_bib22","first-page":"F85","article-title":"Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation","volume":"241","author":"Hostetter","year":"1981","journal-title":"Am J Physiol"},{"issue":"20","key":"10.1016\/j.mayocp.2026.06.015_bib23","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2026.06.015_bib24","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2026.06.015_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2021070942","article-title":"Hyperkalemia risk with finerenone: results from the FIDELIO-DKD trial","volume":"33","author":"Agarwal","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"10193","key":"10.1016\/j.mayocp.2026.06.015_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mayocp.2026.06.015_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11892-018-0991-7","article-title":"Renal effects of incretin-based diabetes therapies: pre-clinical predictions and clinical trial outcomes","volume":"18","author":"Thomson","year":"2018","journal-title":"Curr Diab Rep"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619626185942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619626185942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:53:01Z","timestamp":1785739981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619626185942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0025619626185942"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2026.06.015","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Physiologic Basis of Acute Glomerular Filtration Rate Decline With Renoprotective Therapies","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}